Patents by Inventor Sergey V. Kozin

Sergey V. Kozin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CXCR4 AS A SENSITIZER TO CANCER THERAPEUTICS
    Publication number: 20160128974
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Application
    Filed: September 1, 2015
    Publication date: May 12, 2016
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura
  • Anti-CXCR4 as a sensitizer to cancer therapeutics
    Patent number: 9155723
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: October 13, 2015
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura
  • ANTI-CXCR4 AS A SENSITIZER TO CANCER THERAPEUTICS
    Publication number: 20130216531
    Abstract: Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 22, 2013
    Inventors: Rakesh K. Jain, Dan G. Duda, Sergey V. Kozin, Dai Fukumura
  • Use of Angiopoietins in Tumor Therapy
    Publication number: 20080193461
    Abstract: The present invention provides methods for decreasing tumor growth in a subject that rely on detecting an increase in the expression of angiopoietin-1 or a decrease in the expression of angiopoietin-2 in the tumor or in the bloodstream of the subject to detect the normalization window in tumor vasculature.
    Type: Application
    Filed: December 20, 2005
    Publication date: August 14, 2008
    Applicant: The General Hospital Corporation
    Inventors: Rakesh K. Jain, Frank Winkler, Ricky Tong, Sergey V. Kozin